Name | ethyl 4-[[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl]amino]benzoate |
---|---|
Synonyms |
N-(4-(Ethoxycarbonyl)phenyl)retinamide
viaminate 4-(Ethoxycarbophenyl)retinamide 4-(Carboethoxyphenyl)retinamide retinamide ethyl benzoate Retinamide,N-(4-(ethoxycarbonyl)phenyl) |
Description | Viaminate is a derivative of Retinoic acid, which is used for the treatment of severe acne and other keratinization disorders. |
---|---|
Related Catalog | |
In Vitro | Viaminate is an amide compound formed by Tretinoin and Ethyl p-aminobenzoate, in which the end group of Tretinoin is transformed into amide and ester chain[1]. |
References |
[1]. Zhang H, et al. Fatal Hepatotoxicity Due to Viaminate. Am J Med Sci. 2018 Jul;356(1):84-86. |
Density | 1.071 g/cm3 |
---|---|
Boiling Point | 619.4ºCat 760 mmHg |
Melting Point | 177-182 °C |
Molecular Formula | C29H37NO3 |
Molecular Weight | 447.61 |
Flash Point | 328.4ºC |
Exact Mass | 447.27700 |
PSA | 55.40000 |
LogP | 7.40640 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Hazard Codes | Xi |
---|